Prognostic Value and Clinical Relevance of the 6th Edition 2002 American Joint Committee on Cancer Staging System in Patients with Resectable Hepatocellular Carcinoma

Journal of the American College of Surgeons

Volumn 203, Issue 4, 2006, Pages 426-435

  Lei, Hao Jan ^a   Chau, Gar Yang ^a   Lui, Wing Yiu ^a   Tsay, Shyh Haw ^a   King, Kuang Liang ^a   Loong, Che Chuan ^a   Wu, Chew Wun ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RELIABILITY; RUPTURE; TIME SERIES ANALYSIS; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33748784851     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2006.06.030     Document Type: Article

References (34)

1. Huang Y.H., Chen C.H., Chang T.T., et al. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery. J Gastroenterol Hepatol 20 (2005) 765-771
2. Marrero J.A., Fontana R.J., Barrat A., et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41 (2005) 707-716
3. Wildi S., Pestalozzi B.C., McCormack L., and Clavien P.A. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 91 (2004) 400-408
4. Fleming I., Cooper J., and Hensen D. Liver AJCC cancer staging manual. 5th ed. (1997), Lippincott-Raven, Philadelphia
5. Liver including intrahepatic bile ducts. In: Greene F., Page D., and Fleming I. (Eds). American Joint Committee on cancer staging manual. 6th ed. (2002), Springer, New York 131-144
6. Vauthey J.N., Lauwers G.Y., Esnaola N.F., et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 20 (2002) 1527-1536
7. Lui W.Y., Chau G.Y., Loong C.C., et al. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma. Arch Surg 130 (1995) 1090-1097
8. Lui W.Y., and Chau G.Y. Operative approaches to hepatocellular carcinoma in the cirrhotic patient. In: Wanebo H.J. (Ed). Surgery for gastrointestinal cancer: a multidisciplinary approach (1997), Lippincott-Raven, Philadelphia 533-539
9. Chau G.Y., Lui W.Y., King K.L., and Wu C.W. Evaluation of effect of hemihepatic vascular occlusion and the Pringle maneuver during hepatic resection for patients with hepatocellular carcinoma and impaired liver function. World J Surg 29 (2005) 1374-1383
10. Edmondson H.A., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 45,900 necropsies. Cancer 7 (1954) 462-503
11. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
12. Chau G.Y., Lui W.Y., Tsay S.H., et al. Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients. J Surg Oncol 66 (1997) 122-126
13. Chiu J.H., Wu L.H., Kao H.L., et al. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?. Hepatology 18 (1993) 96-102
14. Poon R.T., and Fan S.T. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 12 (2003) 35-50
15. Ramacciato G., Mercantini P., Cautero N., et al. Prognostic evaluation of the new American Joint Committee on Cancer/International Union Against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 12 (2005) 289-297
16. Varotti G., Ramacciato G., Ercolani G., et al. Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol 31 (2005) 760-767
17. Marsh J.W., Dvorchik I., Bonham C.A., and Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?. Cancer 88 (2000) 538-543
18. Poon R.T., Fan S.T., Ng I.O., and Wong J. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg 237 (2003) 376-383
19. Lau H., Fan S.T., Ng I.O., and Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 83 (1998) 2302-2311
20. Nonami T., Harada A., Kurokawa T., et al. Hepatic resection for hepatocellular carcinoma. Am J Surg 173 (1997) 288-291
21. Izumi R., Shimizu K., Ii T., et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106 (1994) 720-727
22. Takenaka K., Kawahara N., Yamamoto K., et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 131 (1996) 71-76
23. Poon R.T.P., Fan S.T., Ng I.O.L., and Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma. A critical reappraisal. Ann Surg 231 (2000) 544-551
24. Vauthey J.N., Walsh G.L., Vlastos G., and Lauwers G.Y. Importance of field cancerization in clinical oncology. Lancet Oncol 1 (2000) 15-16
25. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 74 (1994) 2772-2780
26. Chang C.H., Chau G.Y., Lui W.Y., et al. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 139 (2004) 320-325 discussion 326
27. Vauthey J.N., Klimstra D., Franceschi D., et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169 (1995) 28-34 discussion 34-35
28. Bilimoria M.M., Lauwers G.Y., Doherty D.A., et al. Underlying liver diseases, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 136 (2001) 528-535
29. Poon R.T., Fan S.T., Lo C.M., et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 18 (2000) 1094-1101
30. Tarao K., Rino Y., Ohkawa S., et al. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis. Cancer 94 (2002) 1787-1795
31. Leung T.W., Tang A.M., Zee B., et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 94 (2002) 1760-1769
32. Kudo M., Chung H., and Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38 (2003) 207-215
33. Tsai T.J., Chau G.Y., Lui W.Y., et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127 (2000) 603-608
34. Adachi E., Maeda T., Kajiyama K., et al. Factors correlated with portal venous invasion by hepatocellular carcinoma. Univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 77 (1996) 2022-2031